Skip to main navigation
Fennec Pharmaceuticals
  • Home
  • About
    • Fennec Pharma
    • Management Team
    • Board of Directors
  • Product Candidates
    • Development Pipeline
    • STS
  • Clinical Trials
    • COG ACCL0431
    • SIOPEL 6
    • Expanded Access
  • Investors
  • Contact Us
  • Search

Quarterly Results

You are here: Home / Investors / Financial Information / Quarterly Results

    Quarterly Results

    Show all

    2019

    Q4
    • Press Release
    Q3
    • Press Release
    Q2
    • Press Release
    Q1
    • Press Release

    2018

    Q4
    • Press Release
    Q3
    • Press Release
    Q2
    • Press Release
    Q1
    • Press Release

    2017

    Q4
    • Press Release
    Q3
    • Press Release
    Q2
    • Press Release
    Q1
    • Press Release

    2016

    Q4
    • Press Release
    Q3
    • Press Release
    Q2
    • Press Release
    Q1
    • Press Release

    Investor Tools

    • Print Page
    • Email Alerts
    • Contact IR
    • RSS Feeds

    Investor Relations

    • Investor Relations
    • Stock Information
    • News & Events
    • Financial Information
      • SEC Filings
      • SEDAR Filings
      • Financial Reports
      • Quarterly Results
      • Analyst Coverage
      • Earnings Estimates
    • Corporate Governance
    • Investor Resources
    Copyright © 2020 Fennec Pharmaceuticals
    Scroll to top